MedPath

Remote Monitoring in Diabetes Disease Management

Not Applicable
Completed
Conditions
Type 1 Diabetes
Type 2 Diabetes
Interventions
Behavioral: DM-Standard
Behavioral: Disease Management Plus
Registration Number
NCT00675311
Lead Sponsor
LifeScan
Brief Summary

The primary objective of this study is to determine whether remote monitoring in diabetes management is more effective at helping patients manage their disease than a standard disease management program.

Detailed Description

To determine whether remote monitoring in diabetes management is more effective at helping patients manage their disease.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
DM-StandardDM-StandardThe conventional disease management group will receive management under the site's usual program offering, which includes, but is not limited to, compliance with the prescribed treatment regimens, dietary management, exercise programs, and other measures recommended by the American Diabetes Association (ADA) and the Association of American Endocrinologists (AACE).
DM-PlusDisease Management PlusPlus is one of the randomized arms of the study. Patients assigned to this arm receive support from Disease Management nurses and technology that includes mobile phone client software with web-based companion software, Bluetooth glucose meter cradle, and web-based clinical management software for the clinical management team. The core of the system is the patient's cell phone which is used as an input device and which enables patients to maintain an electronic diary of information such as meal times, blood glucose, insulin use, weight, blood pressure, and exercise. The device is customizable to collect only the information relevant to the patient with diabetes and their healthcare provider. The patient with diabetes enters diary information on his or her mobile phone. No immediate or real-time information is provided to patients as part of this study.
Primary Outcome Measures
NameTimeMethod
The primary study measures for this study include glycemic control and LDL levels, satisfaction with diabetes care, and adherence to diabetes medications and self-monitoring recommendations1 Year
Secondary Outcome Measures
NameTimeMethod
Secondary measures include diabetes-related health-care utilization and physiologic data.1 Year
© Copyright 2025. All Rights Reserved by MedPath